IRIS - Res&Arch Institutional Research Information System - Research & Archive

GENTILE, GIORGIO

GENTILE, GIORGIO  

DIPARTIMENTO DI MEDICINA INTERNA (attivo dal 14/09/1994 al 31/12/2013)  

Mostra records
Risultati 1 - 20 di 25 (tempo di esecuzione: 0.021 secondi).
Titolo Data di pubblicazione Autore(i) File
Aliskiren versus ramipril in hypertension. 2010 P., Verdecchia; Angeli, Fabio; G., Mazzotta; P., Martire; M., Garofoli; Gentile, Giorgio; Reboldi, Gianpaolo
Angiotensin-converting enzyme inhibitors 2012 Gentile, Giorgio; Reboldi, Gianpaolo; Angeli, Fabio; G., Mazzotta; P., Verdecchia
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and protection from stroke. 2008 Angeli, Fabio; Gentile, Giorgio; Reboldi, Gianpaolo; P., Verdecchia
Benefits of more intensive versus less intensive blood pressure control. Updated trial sequential analysis 2022 Reboldi, G.; Angeli, F.; Gentile, G.; Verdecchia, P.
Beta-blockers and risk of all-cause mortality in non-cardiac surgery. 2010 Angeli, Fabio; P., Verdecchia; G., Karthikeyan; G., Mazzotta; S., Repaci; M. d., Pinto; Gentile, Giorgio; C., Cavallini; Reboldi, Gianpaolo
Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers. 2012 Verdecchia, P; Gentile, Giorgio; Angeli, Fabio; Reboldi, Gianpaolo
Blood pressure lowering in diabetic patients. 2012 Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; Ambrosio, Giuseppe; G., Mancia; P., Verdecchia
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials. 2009 Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; P., Verdecchia
Comparative assessment of angiotensin receptor blockers in different clinical settings. 2009 P., Verdecchia; Angeli, Fabio; S., Repaci; G., Mazzotta; Gentile, Giorgio; Reboldi, Gianpaolo
Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis. 2008 Reboldi, Gianpaolo; Angeli, Fabio; C., Cavallini; Gentile, Giorgio; G., Mancia; P., Verdecchia
Day-Night Dip and Early-Morning Surge in Blood Pressure in Hypertension: Prognostic Implications 2012 P., Verdecchia; Angeli, Fabio; G., Mazzotta; M., Garofoli; E., Ramundo; Gentile, Giorgio; Ambrosio, Giuseppe; Reboldi, Gianpaolo
Diabete Mellito Complicanze Cardiache e Renali (13 Lemmi) 2007 Reboldi, Gianpaolo; Gentile, Giorgio
Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients 2011 Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; Ambrosio, Giuseppe; Mancia, G; Verdecchia, P.
Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus. 2009 Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; P., Verdecchia
Home Blood Pressure Measurements Will Not Replace 24-Hour Ambulatory Blood Pressure Monitoring. 2009 P., Verdecchia; Angeli, Fabio; G., Mazzotta; Gentile, Giorgio; Reboldi, Gianpaolo
Home Blood Pressure Measurements Will or Will Not Replace 24-Hour Ambulatory Blood Pressure Measurement. 2009 P., Verdecchia; Angeli, Fabio; G., Mazzotta; Gentile, Giorgio; Reboldi, Gianpaolo
Microalbuminuria and hypertension. 2005 Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; Verdecchia, P.
Optimal therapy in hypertensive subjects with diabetes mellitus 2011 Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; Verdecchia, P.
Pharmacokinetic, pharmacodynamic and clinical evaluation of aliskiren for hypertension treatment. 2011 Reboldi, Gianpaolo; Gentile, Giorgio; Angeli, Fabio; Verdecchia, P.
Role and prognostic value of individual ambulatory blood pressure components in chronic kidney disease 2018 Angeli, Fabio; Gentile, Giorgio; Trapasso, Monica; Verdecchia, Paolo; Reboldi, Gianpaolo